vs
Pediatrix Medical Group, Inc.（MD）とEPLUS INC（PLUS）の財務データ比較。上の社名をクリックして会社を切り替えられます
EPLUS INCの直近四半期売上が大きい（$614.8M vs $493.8M、Pediatrix Medical Group, Inc.の約1.2倍）。Pediatrix Medical Group, Inc.の純利益率が高く（6.8% vs 5.7%、差は1.1%）。EPLUS INCの前年同期比売上増加率が高い（20.3% vs -1.7%）。過去8四半期でEPLUS INCの売上複合成長率が高い（2.3% vs -0.1%）
Pediatrix Medical Group, Inc.は米国を代表する専門医療サービスプロバイダーで、母胎医療、新生児科、小児心臓病学などの小児亜専門を中心に事業を展開し、米国全土の医療機関と提携して女性、新生児、子どもに根拠に基づく質の高い医療を提供しています。
ePlus Inc.は米国発のコンサルティング型テクノロジーソリューションプロバイダーで、サイバーセキュリティ、クラウド、ネットワーク、コラボレーション、人工知能などの先進技術分野にわたり、5000社以上の顧客にソリューション、アドバイザリー、マネージドサービスを提供しています。
MD vs PLUS — 直接比較
損益計算書 — Q4 FY2025 vs Q3 FY2026
| 指標 | | |
|---|---|---|
| 売上 | $493.8M | $614.8M |
| 純利益 | $33.7M | $35.1M |
| 粗利率 | — | 25.8% |
| 営業利益率 | 9.9% | 7.1% |
| 純利益率 | 6.8% | 5.7% |
| 売上前年比 | -1.7% | 20.3% |
| 純利益前年比 | 10.5% | 45.2% |
| EPS（希薄化後） | $0.40 | $1.33 |
緑 = その指標でリード。会計年度がずれている場合は期間が異なる場合あり
8四半期 売上・利益トレンド
並べて比較する四半期履歴。決算期がずれていても暦四半期で整列
| Q4 25 | $493.8M | $614.8M | ||
| Q3 25 | $492.9M | $608.8M | ||
| Q2 25 | $468.8M | $637.3M | ||
| Q1 25 | $458.4M | — | ||
| Q4 24 | $502.4M | $493.2M | ||
| Q3 24 | $511.2M | $493.4M | ||
| Q2 24 | $504.3M | $535.7M | ||
| Q1 24 | $495.1M | — |
| Q4 25 | $33.7M | $35.1M | ||
| Q3 25 | $71.7M | $34.9M | ||
| Q2 25 | $39.3M | $37.7M | ||
| Q1 25 | $20.7M | — | ||
| Q4 24 | $30.5M | $24.1M | ||
| Q3 24 | $19.4M | $31.3M | ||
| Q2 24 | $-153.0M | $27.3M | ||
| Q1 24 | $4.0M | — |
| Q4 25 | — | 25.8% | ||
| Q3 25 | — | 26.6% | ||
| Q2 25 | — | 23.3% | ||
| Q1 25 | — | — | ||
| Q4 24 | — | 25.4% | ||
| Q3 24 | — | 25.8% | ||
| Q2 24 | — | 23.7% | ||
| Q1 24 | — | — |
| Q4 25 | 9.9% | 7.1% | ||
| Q3 25 | 13.8% | 8.0% | ||
| Q2 25 | 12.8% | 5.7% | ||
| Q1 25 | 7.0% | — | ||
| Q4 24 | 7.8% | 3.3% | ||
| Q3 24 | 6.6% | 5.5% | ||
| Q2 24 | -31.3% | 5.9% | ||
| Q1 24 | 3.2% | — |
| Q4 25 | 6.8% | 5.7% | ||
| Q3 25 | 14.5% | 5.7% | ||
| Q2 25 | 8.4% | 5.9% | ||
| Q1 25 | 4.5% | — | ||
| Q4 24 | 6.1% | 4.9% | ||
| Q3 24 | 3.8% | 6.3% | ||
| Q2 24 | -30.3% | 5.1% | ||
| Q1 24 | 0.8% | — |
| Q4 25 | $0.40 | $1.33 | ||
| Q3 25 | $0.84 | $1.32 | ||
| Q2 25 | $0.46 | $1.43 | ||
| Q1 25 | $0.24 | — | ||
| Q4 24 | $0.37 | $0.91 | ||
| Q3 24 | $0.23 | $1.17 | ||
| Q2 24 | $-1.84 | $1.02 | ||
| Q1 24 | $0.05 | — |
貸借対照表と財務力
直近四半期の流動性・レバレッジ・純資産のスナップショット
| 指標 | | |
|---|---|---|
| 現金・短期投資手元流動性 | $375.2M | $326.3M |
| 総負債低いほど良い | $570.5M | — |
| 株主資本純資産 | $865.9M | $1.1B |
| 総資産 | $2.2B | $1.8B |
| 負債/資本比率低いほどレバレッジが低い | 0.66× | — |
8四半期トレンド — 暦四半期で整列
| Q4 25 | $375.2M | $326.3M | ||
| Q3 25 | $340.1M | $402.2M | ||
| Q2 25 | $224.7M | $480.2M | ||
| Q1 25 | $99.0M | — | ||
| Q4 24 | $229.9M | $253.1M | ||
| Q3 24 | $103.8M | $187.5M | ||
| Q2 24 | $19.4M | $349.9M | ||
| Q1 24 | $8.0M | — |
| Q4 25 | $570.5M | — | ||
| Q3 25 | $577.2M | — | ||
| Q2 25 | $583.9M | — | ||
| Q1 25 | $590.5M | — | ||
| Q4 24 | $597.1M | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
| Q4 25 | $865.9M | $1.1B | ||
| Q3 25 | $890.7M | $1.0B | ||
| Q2 25 | $833.8M | $1.0B | ||
| Q1 25 | $789.2M | — | ||
| Q4 24 | $764.9M | $962.3M | ||
| Q3 24 | $732.5M | $947.0M | ||
| Q2 24 | $706.5M | $921.9M | ||
| Q1 24 | $856.2M | — |
| Q4 25 | $2.2B | $1.8B | ||
| Q3 25 | $2.2B | $1.8B | ||
| Q2 25 | $2.1B | $1.8B | ||
| Q1 25 | $2.0B | — | ||
| Q4 24 | $2.2B | $1.8B | ||
| Q3 24 | $2.1B | $1.7B | ||
| Q2 24 | $2.0B | $1.7B | ||
| Q1 24 | $2.2B | — |
| Q4 25 | 0.66× | — | ||
| Q3 25 | 0.65× | — | ||
| Q2 25 | 0.70× | — | ||
| Q1 25 | 0.75× | — | ||
| Q4 24 | 0.78× | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
キャッシュフローと資本効率
再投資後に実際に生み出すキャッシュ。純利益より操作が難しい
| 指標 | | |
|---|---|---|
| 営業キャッシュフロー直近四半期 | $114.1M | $-87.4M |
| フリーキャッシュフロー営業CF - 設備投資 | — | — |
| FCFマージンFCF / 売上 | — | — |
| 設備投資強度設備投資 / 売上 | — | — |
| キャッシュ転換率営業CF / 純利益 | 3.39× | -2.49× |
| 直近12ヶ月FCF直近4四半期 | — | — |
8四半期トレンド — 暦四半期で整列
| Q4 25 | $114.1M | $-87.4M | ||
| Q3 25 | $137.3M | $-34.8M | ||
| Q2 25 | $137.2M | $-99.0M | ||
| Q1 25 | $-117.5M | — | ||
| Q4 24 | $133.0M | $65.7M | ||
| Q3 24 | $91.8M | $-21.6M | ||
| Q2 24 | $107.0M | $97.1M | ||
| Q1 24 | $-125.2M | — |
| Q4 25 | 3.39× | -2.49× | ||
| Q3 25 | 1.91× | -1.00× | ||
| Q2 25 | 3.49× | -2.63× | ||
| Q1 25 | -5.66× | — | ||
| Q4 24 | 4.36× | 2.72× | ||
| Q3 24 | 4.72× | -0.69× | ||
| Q2 24 | — | 3.55× | ||
| Q1 24 | -31.03× | — |
財務フロー比較
売上 → 粗利 → 営業利益 → 純利益のサンキー図
セグメント別売上内訳
MD
| Health Care Patient Service | $421.6M | 85% |
| Hospitals Contracts | $70.0M | 14% |
| Other | $2.2M | 0% |
PLUS
| All Others Customer End Market | $107.0M | 17% |
| Technology Customer End Market | $89.4M | 15% |
| Health Care Customer End Market | $81.5M | 13% |
| Financial Services Customer End Market | $66.1M | 11% |
| Professional Services Reporting Unit | $64.1M | 10% |
| Security | $61.1M | 10% |
| State And Local Government And Educational Institutions | $59.9M | 10% |
| Managed Services Reporting Unit | $48.8M | 8% |
| Other Product | $21.1M | 3% |
| Collaboration | $13.4M | 2% |
